Dabigatran and rivaroxaban in the patients with atrial fibrillation and venous thrombembolism: our first clinical experience

<p><strong>ABSTRACT</strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong>Background: </strong>The new oral anticoagulant drugs (NOAC) have shown promising results in the randomized trials in...

Full description

Bibliographic Details
Main Authors: Alenka Mavri, Monika Štalc
Format: Article
Language:English
Published: Slovenian Medical Association 2015-01-01
Series:Zdravniški Vestnik
Subjects:
Online Access:http://vestnik.szd.si/index.php/ZdravVest/article/view/1036